Genomic characterization of an emerging Enterobacteriaceae species: the first case of co-infection with a typical pathogen in a human patient.


Journal

BMC genomics
ISSN: 1471-2164
Titre abrégé: BMC Genomics
Pays: England
ID NLM: 100965258

Informations de publication

Date de publication:
15 Apr 2020
Historique:
received: 20 01 2020
accepted: 05 04 2020
entrez: 16 4 2020
pubmed: 16 4 2020
medline: 14 1 2021
Statut: epublish

Résumé

Opportunistic pathogens are important for clinical practice as they often cause antibiotic-resistant infections. However, little is documented for many emerging opportunistic pathogens and their biological characteristics. Here, we isolated a strain of extended-spectrum β-lactamase-producing Enterobacteriaceae from a patient with a biliary tract infection. We explored the biological and genomic characteristics of this strain to provide new evidence and detailed information for opportunistic pathogens about the co-infection they may cause. The isolate grew very slowly but conferred strong protection for the co-infected cephalosporin-sensitive Klebsiella pneumoniae. As the initial laboratory testing failed to identify the taxonomy of the strain, great perplexity was caused in the etiological diagnosis and anti-infection treatment for the patient. Rigorous sequencing efforts achieved the complete genome sequence of the isolate which we designated as AF18. AF18 is phylogenetically close to a few strains isolated from soil, clinical sewage, and patients, forming a novel species together, while the taxonomic nomenclature of which is still under discussion. And this is the first report of human infection of this novel species. Like its relatives, AF18 harbors many genes related to cell mobility, various genes adaptive to both the natural environment and animal host, over 30 mobile genetic elements, and a plasmid bearing bla Our findings imply that AF18 and its species are not only infection-relevant but also potential disseminators of antibiotic resistance genes, which highlights the need for continuous monitoring for this novel species and efforts to develop treatment strategies.

Sections du résumé

BACKGROUND BACKGROUND
Opportunistic pathogens are important for clinical practice as they often cause antibiotic-resistant infections. However, little is documented for many emerging opportunistic pathogens and their biological characteristics. Here, we isolated a strain of extended-spectrum β-lactamase-producing Enterobacteriaceae from a patient with a biliary tract infection. We explored the biological and genomic characteristics of this strain to provide new evidence and detailed information for opportunistic pathogens about the co-infection they may cause.
RESULTS RESULTS
The isolate grew very slowly but conferred strong protection for the co-infected cephalosporin-sensitive Klebsiella pneumoniae. As the initial laboratory testing failed to identify the taxonomy of the strain, great perplexity was caused in the etiological diagnosis and anti-infection treatment for the patient. Rigorous sequencing efforts achieved the complete genome sequence of the isolate which we designated as AF18. AF18 is phylogenetically close to a few strains isolated from soil, clinical sewage, and patients, forming a novel species together, while the taxonomic nomenclature of which is still under discussion. And this is the first report of human infection of this novel species. Like its relatives, AF18 harbors many genes related to cell mobility, various genes adaptive to both the natural environment and animal host, over 30 mobile genetic elements, and a plasmid bearing bla
CONCLUSIONS CONCLUSIONS
Our findings imply that AF18 and its species are not only infection-relevant but also potential disseminators of antibiotic resistance genes, which highlights the need for continuous monitoring for this novel species and efforts to develop treatment strategies.

Identifiants

pubmed: 32293254
doi: 10.1186/s12864-020-6720-z
pii: 10.1186/s12864-020-6720-z
pmc: PMC7156906
doi:

Substances chimiques

Anti-Bacterial Agents 0
RNA, Untranslated 0
beta-Lactamases EC 3.5.2.6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

297

Subventions

Organisme : National Science and Technology Major Project
ID : 2017ZX10103004-006, 2018ZX10712001-018-002
Organisme : National Natural Science Foundation of China
ID : 81870010, 31970568, 31671350
Organisme : Programs of the Chinese Academy of Sciences
ID : Y8YZ02E001, QYZDY-SSW-SMC017

Références

Nucleic Acids Res. 2017 Jan 4;45(D1):D566-D573
pubmed: 27789705
Environ Microbiol. 2019 Dec;21(12):4597-4613
pubmed: 31385413
Nature. 1988 Sep 22;335(6188):351-2
pubmed: 3047585
Genom Data. 2016 Apr 14;8:61-6
pubmed: 27222800
mBio. 2014 Feb 11;5(1):e00942-13
pubmed: 24520060
J Bacteriol. 2012 Aug;194(16):4438-9
pubmed: 22843579
Genome Biol. 2015 Jan 13;16:1
pubmed: 25583448
Methods Mol Biol. 2020;2075:285-294
pubmed: 31584170
J Bacteriol. 2006 Mar;188(6):2134-43
pubmed: 16513743
Ann N Y Acad Sci. 2017 Jan;1388(1):108-120
pubmed: 28134443
Nucleic Acids Res. 2016 Jul 8;44(W1):W242-5
pubmed: 27095192
Philos Trans R Soc Lond B Biol Sci. 2001 Jul 29;356(1411):983-9
pubmed: 11516376
Clin Microbiol Infect. 2016 Aug;22(8):737.e1-7
pubmed: 27269884
Science. 2013 Sep 27;341(6153):1514-7
pubmed: 24030491
Nat Prod Rep. 2018 Apr 25;35(4):303-308
pubmed: 28884173
Nucleic Acids Res. 2004 Jan 1;32(Database issue):D258-61
pubmed: 14681407
Nat Commun. 2018 Nov 30;9(1):5114
pubmed: 30504855
Nucleic Acids Res. 2001 Jun 15;29(12):2607-18
pubmed: 11410670
Genome Announc. 2017 Oct 26;5(43):
pubmed: 29074664
BMJ. 2016 Feb 08;352:h6420
pubmed: 26858245
Philos Trans R Soc Lond B Biol Sci. 2015 Jun 5;370(1670):20140083
pubmed: 25918441
Front Microbiol. 2018 Nov 22;9:2853
pubmed: 30524415
Infect Genet Evol. 2017 Oct;54:108-127
pubmed: 28658607
Int J Syst Evol Microbiol. 2016 Dec;66(12):5575-5599
pubmed: 27620848
Genome Res. 2009 Sep;19(9):1639-45
pubmed: 19541911
Nucleic Acids Res. 2016 Jan 4;44(D1):D682-7
pubmed: 26433226
Nucleic Acids Res. 2017 Jul 3;45(W1):W435-W439
pubmed: 28472523
Genomics Proteomics Bioinformatics. 2017 Feb;15(1):14-18
pubmed: 28387199
Nat Commun. 2019 Nov 6;10(1):5029
pubmed: 31695033
Bioinformatics. 2005 Feb 15;21(4):537-9
pubmed: 15479716
J Perinatol. 2013 Aug;33(8):581-5
pubmed: 23538645
Nucleic Acids Res. 2013 Aug;41(14):e140
pubmed: 23716638
Genome Announc. 2016 Dec 22;4(6):
pubmed: 28007864
Front Microbiol. 2018 Dec 21;9:3077
pubmed: 30627119
J Bacteriol. 2008 Apr;190(8):2841-50
pubmed: 18263727
mBio. 2018 Feb 6;9(1):
pubmed: 29437920
FEMS Microbiol Rev. 2019 Mar 1;43(2):123-144
pubmed: 30452654
Nat Commun. 2019 Jun 14;10(1):2643
pubmed: 31201324
Nucleic Acids Res. 2000 Jan 1;28(1):33-6
pubmed: 10592175
PLoS One. 2010 Mar 10;5(3):e9490
pubmed: 20224823
Bioinformatics. 2015 Sep 1;31(17):2877-8
pubmed: 25913206
Science. 2013 Sep 27;341(6153):1460-1
pubmed: 24030495
Nucleic Acids Res. 2000 Jan 1;28(1):27-30
pubmed: 10592173
Antimicrob Agents Chemother. 1996 Jul;40(7):1736-40
pubmed: 8807075
Commun Biol. 2019 Aug 8;2:301
pubmed: 31428689
Nucleic Acids Res. 2019 Jan 8;47(D1):D94-D99
pubmed: 30365038
Nucleic Acids Res. 2020 Jan 8;48(D1):D24-D33
pubmed: 31702008
Nucleic Acids Res. 2019 Jan 8;47(D1):D687-D692
pubmed: 30395255
Antimicrob Agents Chemother. 2016 May 23;60(6):3767-78
pubmed: 27067320
Philos Trans R Soc Lond B Biol Sci. 2017 Jan 19;372(1712):
pubmed: 27920384
Nucleic Acids Res. 2008 Jul 1;36(Web Server issue):W5-9
pubmed: 18440982
Genome Biol. 2016 Jun 20;17(1):132
pubmed: 27323842
BMC Bioinformatics. 2009 Dec 15;10:421
pubmed: 20003500
Nucleic Acids Res. 2007;35(9):3100-8
pubmed: 17452365

Auteurs

Zhao Zhang (Z)

Department of Respiratory & Critical Care Medicine, Peking University People's Hospital, Beijing, Beijing, China.
Department of Respiratory & Critical Care Medicine, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.

Daixi Li (D)

Department of Respiratory & Critical Care Medicine, Peking University People's Hospital, Beijing, Beijing, China.
Department of Respiratory and Critical Care Medicine, Zhongshan Hospital Xiamen University, Xiamen, 361004, Fujian, China.

Xing Shi (X)

Department of Respiratory & Critical Care Medicine, Peking University People's Hospital, Beijing, Beijing, China.
Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, Beijing, China.

Yao Zhai (Y)

University of Technology Sydney, Ultimo, NSW, Australia.

Yatao Guo (Y)

Department of Respiratory & Critical Care Medicine, Peking University People's Hospital, Beijing, Beijing, China.
Department of Respiratory & Critical Care Medicine, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.

Yali Zheng (Y)

Department of Respiratory & Critical Care Medicine, Peking University People's Hospital, Beijing, Beijing, China.
Department of Respiratory, Critical Care and Sleep Medicine, Xiamen University Xiang'an Hospital, Xiamen, Fujian, China.

Lili Zhao (L)

Department of Respiratory & Critical Care Medicine, Peking University People's Hospital, Beijing, Beijing, China.

Yukun He (Y)

Department of Respiratory & Critical Care Medicine, Peking University People's Hospital, Beijing, Beijing, China.

Yusheng Chen (Y)

Department of Respiratory & Critical Care Medicine, Fujian Provincial Hospital, Fuzhou, Fujian, China.

Zhanwei Wang (Z)

Laboratory Medicine, Peking University People's Hospital, Beijing, China.

Jianrong Su (J)

Department of Clinical Laboratory Center, Beijing Friendship Hospital, Beijing, Beijing, China.

Yu Kang (Y)

Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, Beijing, China. kangy@big.ac.cn.

Zhancheng Gao (Z)

Department of Respiratory & Critical Care Medicine, Peking University People's Hospital, Beijing, Beijing, China. zcgao@bjmu.edu.cn.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH